Keyphrases
Contrast Probe
100%
Time Tracking
100%
MR Contrast
100%
Gene Therapy
100%
Monogenetic Diseases
66%
Storage Diseases
66%
Magnetic Resonance Imaging
66%
Adenovirus
66%
Neurological Disorders
66%
Contrast Agent
66%
Enzymatic Deficiency
33%
Ca(II)
33%
Diagnostic Radiology
33%
Gd(III)
33%
MR Contrast Agents
33%
Non-invasive Way
33%
In Vivo Gene Delivery
33%
Clinical Disease Progression
33%
Virus Gene
33%
True 3D
33%
Gd3+
33%
Mean Survival Time
33%
Zn(II)
33%
Enzyme-activated
33%
Small Combination of Slices
33%
Peripheral Nervous System
33%
Gene Therapy Trials
33%
Treatment Modalities
33%
Contrast Enhancement
33%
PH-sensitive
33%
Spinal muscular Atrophy
33%
Structural Information
33%
Redox
33%
Enzymatic Activity
33%
Central Nervous System
33%
Lag Time
33%
Biodistribution
33%
Gene number
33%
Genotype-phenotype Association
33%
Virus Therapy
33%
Survival Rate
33%
Activity Level
33%
Hemophilia
33%
Bioresponsive
33%
Therapeutic Target
33%
Monogenic
33%
3D Imaging
33%
Lysosomal Storage Disease
33%
Ionizing Radiation
33%
Pharmacology, Toxicology and Pharmaceutical Science
Contrast Medium
100%
Adeno Associated Virus
100%
Storage Disease
100%
Neurologic Disease
100%
Disease
100%
Prevalence
50%
Ionizing Radiation
50%
Disease Exacerbation
50%
Biodistribution
50%
Clinical Trial
50%
Magnetic Resonance Contrast Agent
50%
Spinal Muscular Atrophy
50%
Survival Rate
50%
Lysosome Storage Disease
50%
Virotherapy
50%
Haemophilia A
50%
Gene Delivery
50%
Medicine and Dentistry
Gene Therapy
100%
Adeno-Associated Virus
50%
Neurologic Disease
50%
Storage Disease
50%
Contrast Medium
50%
Diseases
50%
Magnetic Resonance Imaging
50%
3D Imaging
25%
Prevalence
25%
Survival Rate
25%
Disease Exacerbation
25%
Spinal Muscular Atrophy
25%
Enzyme Activity
25%
Virus Gene
25%
Medicine
25%
Biodistribution
25%
Ionizing Radiation
25%
Clinical Trial
25%
Lysosomal Storage Disease
25%
Magnetic Resonance Contrast Agent
25%
Peripheral Nervous System
25%
Radiodiagnosis
25%
in Vivo Gene Transfer
25%
Central Nervous System
25%
Virotherapy
25%
Haemophilia A
25%